Recombinant IFNA1 (Rontalizumab Biosimilar) antibody
The Humanized Chimeric anti-IFNA1 (Rontalizumab Biosimilar) antibody (ABIN7597958) specifically detects IFNA1 (Rontalizumab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7597958
$394.62
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant IFNA1 (Rontalizumab Biosimilar) antibody (ABIN7597958)
Target
IFNA1 (Rontalizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This IFNA1 (Rontalizumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Rontalizumab Biosimilar Antibody
-
Specificity
- LeIF D, Interferon alpha-1/13, IFNA1, Interferon alpha-D, IFN-alpha-1/13
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- IFNA1 (Rontalizumab Biosimilar)
-
Alternative Name
- Rontalizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- LeIF D, Interferon alpha-1/13, IFNA1, Interferon alpha-D, IFN-alpha-1/13
-
UniProt
- P01562
-
CAS-No
- 948570-30-7
Target
-
You are here:
